Coly-Mycin S Otic
"Sounds surround us. We enjoy many of themâ€”like music, birdsong, and conversations with friends. But loud or long-lasting noisesâ€”from motors, power tools, and even headphonesâ€”can permanently damage your hearing. Take steps to protect your ears "...
Coly-Mycin S Otic
Coly-Mycin S Otic Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Coly-Mycin S Otic (colistin sulfate, neomycin sulfate, thonzonium bromide, hydrocortisone acetate) is used to treat ear infections caused by bacteria. Colistin and neomycin are antibiotics, hydrocortisone is a steroid, and thonzonium is a wetting agent. Common side effects include temporary stinging or burning of the ear for a minute or two when applied.
For adults, the recommended dose of Coly-Mycin S Otic is to instill 5 drops of the suspension into the affected ear 3 or 4 times daily. For pediatric patients, 4 drops are suggested because of the smaller capacity of the ear canal. Other drugs may interact with Coly-Mycin S Otic. Tell your doctor all medications and supplements you use. Coly-Mycin S Otic should be used only if prescribed during pregnancy. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.
Our Coly-Mycin S Otic (colistin sulfate, neomycin sulfate, thonzonium bromide, hydrocortisone acetate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Coly-Mycin S Otic in Detail - Patient Information: Side Effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have a serious side effect such as:
- skin rash, redness, swelling, itching, dryness, or scaling;
- hearing loss; or
- urinating less than usual or not at all.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Coly-Mycin S Otic (Colistin Sulfate with Neomycin and Hydrocortisone ) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Coly-Mycin S Otic FDA Prescribing Information: Side Effects
Neomycin occasionally causes skin sensitization.
Ototoxicity (see WARNINGS section) and nephrotoxicity have also been reported.
Adverse reactions have occurred with topical use of antibiotic combinations. Exact incidence figures are not available since no denominator of treated patients is available. The reaction occurring most often is allergic sensitization. In one clinical study, using a 20% neomycin patch, neomycin-induced allergic skin reactions occurred in two of 2,175 (0.09%) individuals in the general population. In another study the incidence was found to be approximately 1%.
The following local adverse events have been reported with topical corticosteroids, especially under occlusive dressings: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Read the entire FDA prescribing information for Coly-Mycin S Otic (Colistin Sulfate with Neomycin and Hydrocortisone ) »
Additional Coly-Mycin S Otic Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.